Regenerative biotechnology

CTM Biodent Gingiva

Injectable solution with mesenchymal stem cells for regeneration of affected gingival tissue.

Product based on placenta-derived mesenchymal stem cells that promote regeneration of gingival tissue and restoration of damaged periodontal structures.
View technical sheet

Composition

Placenta-derived mesenchymal stem cells.

Pharmaceutical form

Injectable solution.

Monovette with 4 ml.

Plastic monovette with 1 ml, 5 million cells.

Therapeutic Properties

Promotes gingival regeneration through the release of trophic factors with antiapoptotic, antifibrotic, angiogenic, and mitotic effects, in addition to local immunological modulation.
  • Gingival tissue regeneration.
  • Immune system modulation.
  • Local angiogenic stimulation.
  • Reduction of periodontal inflammation.
  • Periodontal ligament repair.
  • Root cementum regeneration.
  • Alveolar bone regeneration.
  • Improvement of periodontal condition.

Mechanism of action & Clinical data

Release of trophic factors and extracellular vesicles that modulate inflammation, immunity, and promote regeneration of periodontal tissues.

Indications

Regeneration of gingival tissue in cases of loss or recession due to periodontal disease, trauma, or surgical interventions.

Administration

Intrafilamentary by injection into free or marginal gingiva; application by a trained professional, at intervals of 4 to 6 weeks.

Contraindications

Sensitivity to formula components and diagnosis of neoplasia.

Storage

Refrigerate between 2 and 8 ℃, protect from light, do not freeze, administer within a maximum of 24 hours after receipt.
PRODUCT FOR EXCLUSIVE USE BY HEALTHCARE PROFESSIONALS. APPLICATION UNDER MEDICAL PROTOCOLS.

I want to be contacted

    CTM Biodent Gingiva